News of the first takers of the desperately awaited Pfizer-BioNTech coronavirus vaccine spurred some hope and excitement amid new lockdowns and spiraling infections in much of the US and the UK. But in Russia, one of the few countries already offering vaccines to a wider segment of the general public, the turnout in the first two weeks of “large-scale” vaccination has been less than enthusiastic.

These tiny swirls on the sun could trigger solar flares
Bullfrogs may have an antidote to deadly shellfish poisoning
Is AI making us dumber? Maybe not. But our skills are at risk
Emperor penguin chicks like these starved. An iceberg may be the cause
Naked mole-rat queens rule their colonies with a potent odor
‘Cheating’ birds change their tune
Hiroshima fosters hope, 81 years on from nuclear catastrophe
The Year of Pastoralists Must Be More Than Symbolic
Rohingya Refugees Seeking Safe Haven in Bangladesh Hit by Fresh Disasters